Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03475498 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Major Determinant Focused on the ECG or Echocardiogram for PICM and Its Clinical Outcome (PICM Syndrome)

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment target: 500 to 1000v6 Show 5 more changesShow less
    • Primary completion date: Feb 28, 2023 to Feb 28, 2027
    • Study sites: 2 to 3
    • Start date: Mar 1, 2018 to Jan 30, 2018
    • Eligibility criteria shortened, about 15 words
    • Collaborators: 3 to 4
  2. Publications: 1 to 2v5
  3. Study sites revised (2)
    • Publications: details revised at 1 of 1 entry
    • Study description expanded, about 4 words
    v4
  4. Eligibility criteria shortened, about 13 words
    • Study description expanded, about 43 words
    • Study title expanded, about 6 words
    v3
  5. Primary endpoint revised
    • Eligibility criteria expanded, about 31 words
    • Secondary endpoint revised
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Chronic right ventricular pacing has a deleterious effect on left ventricular (LV) function, namely pacing-induced cardiomyopathy (PICM). Several parametes make difference of effect on the occurrence of PICM and its subsequent clinical outcomes. In particular, recognition of a major determinant focused on the ECG or echocardiographic parameters including strain or genetic factor for occurrence of PICM may lead to better identification of patients at high risk. Investigators prospectively enroll a participant with documented high risk of PICM and clinically follow-up to idenify clinical impact of PICM (PICM syndrome) over a long period of time.
Trial Details
NCT Number NCT03475498
Lead Sponsor Eulji University Hospital
Collaborators: Chungnam National University Hospital, Chungbuk National University Hospital, Dankook University, Chung-Ang University Hospital
Conditions
(from sponsor)		 Pacemaker Complication
Enrollment 1,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov